• Affordable prescription drugs, 340B Program, HR985 FAST Generics Act of 2019, Site Neutral payment policies, S. 1895 - Lower Health Care Costs Act, S. 340 - CREATES Act, H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act, S. 1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019, S. 1531 - Stop the Outrageous Practice of Surprise Medical Bills Act of 2019
• Site Neutral payment policies, Medicare for All, Medicare Buy In, Affordable prescription drugs, Medicaid DSH, Medicare bad debt, wage index
• Affordable prescription drugs, 340B program, drug shortages
• MISSION Act Implementation

Duration: January 1, 2008 to June 30, 2019

General Issues: Health Issues, Medicare/Medicaid, Pharmacy, Veterans, Taxation/Internal Revenue Code

Spending: about $11,200,468 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: House of Representatives, U.S. Senate, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA), Office of Faith-Based & Community Initiatives, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Congressional Budget Office (CBO), Agency for Health Care Policy & Research, Centers For Medicare and Medicaid Services (CMS), White House Office, Health & Human Services - Dept of (HHS),, White House Office,